Introduction {#Sec1}
============

Complementary and alternative medicine (CAM) has been largely ignored by health economists as an area of research. That fact is possibly related to the low esteem of CAM in the medical profession.

Defining CAM is difficult, because the field is very broad and constantly changing. According to the National Center for Complementary and Alternative Medicine (NCCAM), CAM is a group of diverse medical and healthcare systems, practices, and products that are not generally considered part of conventional medicine \[[@CR1]\]. The Cochrane Collaboration definition of complementary medicine is that it includes all such practices and ideas that are outside the domain of conventional medicine in several countries and defined by its users as preventing or treating illness, or promoting health and well-being. These practices complement mainstream medicine by satisfying a demand not met by conventional practices and diversifying the conceptual framework of medicine \[[@CR2]\].

Patients around the globe are increasingly embracing CAM as a contributor to health. A recent study by the US National Institute of Health shows that 4 out of 10 Americans used some form of CAM in 2007. Another study on Switzerland reported that almost 11% of the population had used one of five CAM streams (anthroposophic medicine, homeopathy, neural therapy, phytotherapy, and Traditional Chinese Medicine) in 2002. The CAM doctors in that study treated patients that tended to be younger, female, and better educated. These patients also tended to have a favorable attitude toward complementary medicine and to exhibit chronic and more severe forms of disease. The majority of alternative medicine users appear to have chosen CAM mainly because they wish to undergo a certain procedure; additional reasons include desire for more comprehensive treatment and expectation of fewer side effects \[[@CR3]\]. In a referendum in Switzerland in 2009, two-thirds of the voters were in favor of a wider coverage of CAM by public health insurance. In January 2011, based on the positive outcome of a national referendum, the Swiss authorities decided that five main streams of CAM (anthroposophic medicine, homeopathy, neural therapy, phytotherapy, and Traditional Chinese Medicine) will be covered by the mandatory health insurance for a period of 6 years (2012--2017) \[[@CR4]\].

In many cases, the effectiveness of CAM has not been proven in clinical trials \[[@CR5]\]. However, lack of proof of effectiveness is obviously not the same as proof of ineffectiveness. Clearly, the status of a treatment can change from CAM into conventional medicine once scientific evidence on effectiveness becomes available. Two examples of CAM treatments that have become (more) accepted by conventional medicine are St. John's wort and acupuncture for specific indications. St. John's wort, for more than 90 years used in anthroposophic medicine, has become part of the conventional guidelines for the treatment of depression, based on scientific evidence from randomized controlled trials \[[@CR6]\]. Hopton and McPherson \[[@CR7]\] conclude on the basis of a systematic review of pooled data from meta-analyses that acupuncture is more than a placebo for commonly occurring chronic pain conditions. In addition, in her thesis, van den Berg \[[@CR8]\] recently demonstrated positive effects of acupuncture on obstetric health problems (breech presentation). Also, Servan-Schreiber \[[@CR9]\] presents a series of recent examples of the transition from CAM to conventional medicine in depression treatment. Some of the methods described by Servan-Schreiber have been practiced for centuries, cannot be patented, and are available at low costs. These findings underscore the fact that methods that are considered CAM today could be effective and have a large cost-saving potential.

Anthroposophic medicine, acupuncture, and homeopathy are three main streams of CAM. One of the core features of CAM is its orientation on preventative and curative health promotion as an additional approach to a more conventional fighting disease approach. Anthroposophic medicine is an integrative diagnosis and therapy concept, developed from 1921 onwards and practiced today in over 60 countries. It combines mainstream scientific medicine with Rudolf Steiner's anthroposophy. Anthroposophic medicine considers a human being as a whole entity---body, mind, soul, and individuality. It aims to stimulate the self-healing forces of the body, restoring the balance of bodily functions, and strengthening the immune system, rather than primarily relieve the symptoms of disease. Specific anthroposophic approaches include anthroposophic medicinal products, massage therapy, art and music therapy, and speech and movement therapies \[[@CR10]\].

Homeopathy is a form of alternative medicine, first proposed by the German physician Samuel Hahnemann in 1796, that attempts to treat patients with heavily diluted substances. These substances that cause certain symptoms in healthy individuals are given as the treatment for patients exhibiting similar symptoms. The appropriate homeopathic medicinal product aims to stimulate the body's inherent forces of self-recovery \[[@CR11]\].

Acupuncture is one of the main forms of treatment in Traditional Chinese Medicine (TCM). It involves the use of sharp, thin needles that are inserted in the body at very specific points. This process is believed to adjust and alter the body's energy flow into healthier patterns and is used to treat a wide variety of illnesses and health conditions \[[@CR12]\].

In their review, Herman et al. \[[@CR13]\] report that some studies indicate that CAM therapies may be considered cost-effective compared with usual care for various conditions: acupuncture for migraine, manual therapy for neck pain, spa therapy for Parkinson's, self-administered stress management for cancer patients undergoing chemotherapy, preoperative and postoperative oral nutritional supplementation for lower gastrointestinal tract surgery, biofeedback for patients with 'functional' disorders (e.g., irritable bowel syndrome), and guided imagery, relaxation therapy, and potassium-rich diet for cardiac patients. A systematic review of randomized clinical trials on the use of so-called natural health products shows evidence of cost-effectiveness in relation to postoperative surgery but not with respect to the other conditions assessed \[[@CR14]\]. Studer and Busato \[[@CR15]\] demonstrated that general practitioners who have completed certified additional training in CAM after obtaining their conventional medical degree (GP-CAMs) (*n* = 257) compared with general practitioners who have not (GPs) (*n* = 174) have equal costs per patient per year, but significantly lower costs per doctor (29%) per year, although GP-CAMs take more time per patient. A NCCAM study in 2007 demonstrated that CAM costs were 11.2% of total out-of-pocket expenditures on healthcare in the USA \[[@CR16]\].

GP care varies between European countries in terms of structure, working methods, and responsibilities. In the Netherlands, GPs are the central gatekeepers for reference to the rest of healthcare, like specialists and paramedics. Dutch general practitioners generally receive a quarterly fixed fee per patient plus a fee-for-service per consultation and per drug prescription. There is no difference between the financial incentives faced by GPs and GP-CAMs. In the Netherlands, purchasing basic health insurance is mandatory for all citizens. In addition, citizens are free to purchase supplementary insurance.

Since there is a lack of cost-effectiveness data of CAM in the Netherlands, in this paper, we compare the performance of general practitioners who have completed certified additional training in CAM after obtaining their conventional medical degree (GP-CAMs) with general practitioners who have not (GPs). More specifically, we consider GP-CAMs with additional training in anthroposophic medicine, homeopathy, or acupuncture (about 1% of GPs for each of these CAM types).

Methods {#Sec2}
=======

Model overview {#Sec3}
--------------

We analyze costs at the patient level using linear and log-linear regression analysis. While the linear specification is more common, the log-linear specification can be argued to be more appropriate given that costs are nonnegative and cost distributions typically have long tails. Given the large average differences in health and healthcare needs across age groups, the cost analysis has been performed separately for the age groups 0--24, 25--49, 50--74, and 75+. In all cost regressions, the explanatory variables are gender, age (linear, within each age category), dummies for each quarter, dummies for anthroposophy, homeopathy, and acupuncture, and 6-digit postal code fixed effects.

Effects on mortality rates are analyzed using a Logit model with fixed effects at the 4-digit insuree postcode level. Given the relatively low proportion of deaths (less than 3% of insurees died during our sampling period), fixed effects at 6-digit insuree level are infeasible. To check for robustness against functional form specification, we also analyze mortality using fixed effects linear probability models.

Dataset on healthcare costs and demographics {#Sec4}
--------------------------------------------

A dataset from health insurer Azivo, active primarily in the city of Hague and its wider vicinity, was used for the analyses. Azivo is a former *Ziekenfonds* (sick fund) founded in 1895. It merged with health insurer Menzis in 2008 but keeps operating as "Azivo" in the Hague region. Its share in the market for basic and supplementary health insurance in this region is about one quarter.

The dataset contains quarterly information on the healthcare costs of all Azivo insurees for the years 2006 up to 2009. In addition, it contains the date of birth of the insuree, date of death (if applicable), gender, and 6-digit postcode of the insuree's residence. For each insuree-quarter combination, information on the costs of four different types of care is available: care by GP, hospital care, pharmaceutical care, and paramedic care (like physical therapy). The dataset does not contain information on the supplementary insurance *status* of insures; the cost information is the sum of expenses covered by both the basic and (if applicable) supplementary health insurance.

General practitioners {#Sec5}
---------------------

The dataset also contains the names and addresses of the general practitioners who have patients who are insured by Azivo, which allows us to distinguish between conventional GPs and GP-CAMs. We defined a general practitioner as anthroposophic GP-CAM if his or her name appears in the list of general practitioners with additional training in anthroposophic medicine as provided by their professional association \[[@CR17]\]. GP-CAMs with homeopathy \[[@CR18]\] and GP-CAMs with acupuncture \[[@CR19]\] are defined similarly.

Statistical analyses {#Sec6}
--------------------

Significance of coefficients is tested using *t* tests, with clustering of standard errors at the level of the insuree. Calculations were made using StataSE 10.0.

Results {#Sec7}
=======

Patient demographics {#Sec8}
--------------------

The dataset contained information on 151,952 insurees with a mean age of 38.4 (SD = 22.6); 53% are women. These patients live in 21,902 different 6-digit postal codes.

General practitioners {#Sec9}
---------------------

The dataset contained information from 1992 GPs: 1913 conventional GPs and 79 complementary GPs (GP-CAM) (anthroposophy: 26, homeopathy: 28, acupuncture: 25). The number of patients insured with Azivo is highly unevenly distributed across GPs. For example, 5 out the 26 anthroposophic GPs in the dataset account for more than 95% of the claims by patients with anthroposophic GP. This is because Azivo has a relatively large market share (about one quarter) in the Hague region and a very low market share in most other regions. The average number of Azivo patients with these 5 anthroposophic GPs is about 570. The corresponding figures for the other GP types are 850 (conventional), 150 (homeopathy), and 360 (acupuncture). The differences can be due to variations in the size of the total practice as well as in variations in Azivo's market share across the four groups of patients.

Healthcare costs {#Sec10}
----------------

The costs of patients with a GP-CAM are 7% lower compared with conventional GPs, which amounts to 140 Euros per patient annually. However, this difference in raw means of total costs is significant only for anthroposophic GP-CAMs. The lower total costs result from lower hospital and pharmaceutical costs. Patients with a GP-CAM have slightly higher costs for paramedic care, but this difference is small. When the costs are compared by age group, in absolute terms, the differences are particularly large for patients aged 75 and above with an anthroposophic GP-CAM (1,000 Euros on an annual basis) (Table [2](#Tab2){ref-type="table"}).

The analyses also demonstrate large demographic differences between patients with a conventional GP versus patients with GP-CAMs (Table [1](#Tab1){ref-type="table"}). GP-CAMs have a larger fraction of female patients than conventional GPs and fewer patients from disadvantaged neighborhoods. Clearly, the cost differences reported in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} are partly due to differences in the demographic composition of the various groups of patients and therefore difficult to interpret.Table 1Descriptive statistics on patients with GPs and GP-CAMsGPGP-CAMsConventional GPGP-CAM anthroposophyGP-CAM homeopathyGP-CAM acupuncture*Costs of healthcare*Total515^a^479\*\*\*485480GP3233\*\*\*31\*\*\*32Hospital266236\*\*\*251235\*\*Pharmaceutical209197\*192206Paramedic913\*\*\*10\*\*8\**Incidence of costs of healthcare (0/1)* (per quarter)GP1111Hospital0.290.28\*\*\*0.26\*\*\*0.30Pharmaceutical0.680.67\*\*\*0.62\*\*\*0.65\*\*\*Paramedic0.040.06\*\*\*0.04\*\*0.04\*\*Hosp., Pharma, and/or Paramedic0.720.71\*0.66\*\*\*0.69\*\*\**Mortality*0.0260.0210.038\*\*0.025*Insuree characteristics*Female (fraction)0.530.57\*\*\*0.56\*\*\*0.54\*\*\*Birth year (average)19691970\*\*\*1965\*\*\*1966\*\*\*Disadvantaged neighborhood (fraction)^b^0.220.09\*\*\*0.07\*\*\*0.04\*\*\*Number of Azivo insurees151,9523,2711,1811,470Number of GPs1,913262825\*\*\*, \*\*, \* indicate a statistically significant difference with conventional GP at the 1, 5, and 10% level, respectively^a^Costs of healthcare are in Euros per quarter^b^Based on a government list of most disadvantaged neighborhoods in the Netherlands ("Vogelaar-wijken"). These neighborhoods are uniquely identified by their 4-digit postal codeTable 2Costs of healthcare; by type of GP and insuree age categoryGPsGP-CAMs*Costs of healthcare* (euros per quarter)Conventional GPGP-CAM anthroposophyGP-CAM homeopathyGP-CAM acupuncture*Age 0*--*24*Total215^a^190275191GP262624\*\*\*25Hospital10385\*153\*\*96Pharmaceutical77698862Paramedic811\*\*\*108*Age 25*--*49*Total372418\*\*\*286\*\*296\*\*\*GP2831\*\*\*25\*\*\*26\*\*\*Hospital186201156146\*\*Pharmaceutical155180\*\*\*103\*\*\*122\*\*Paramedic47\*\*\*31\*\*\**Age 50*--*74*Total824752\*\*614\*\*\*687\*\*\*GP3739\*\*\*35\*\*\*35\*\*\*Hospital432382\*\*270\*\*\*324\*\*\*Pharmaceutical342311\*\*294\*317Paramedic1219\*\*\*14\*11*Age 75*+Total1,3371,088\*\*1,3091,139\*GP57575956Hospital727576\*\*820595Pharmaceutical527426\*\*403\*466Paramedic27302721\*\*\*, \*\*, \* indicate a statistically significant difference with conventional GP at the 1, 5, and 10% level, respectively^a^Costs of healthcare are in Euros per quarter

After controlling for these demographic differences by means of regression analyses, we find that for patients in the age group 25--49 with a GP-CAM with acupuncture, total costs are 66 Euro lower per quarter (Table [3](#Tab3){ref-type="table"}, left panel). Secondly, for patients aged 75 and above with an anthroposophic GP-CAM, total costs are about 400 Euros lower per quarter. The magnitude of this difference is large, about one-third lower. The separate regressions for the costs components show that these lower costs come from lower hospital and lower pharmaceutical costs. The results for the log-linear specification show a somewhat different pattern. Homeopathic GP-CAMs have about 15% lower costs in all three age categories below age 75. The lower costs for patients aged 25--49 who have a GP-CAM with acupuncture are found again for the log-linear specification.Table 3Effects of complementary care on costs per insuree age categoryLinearLog-linearDummy for GP-CAM anthroposophyDummy for GP-CAM homeopathyDummy for GP-CAM acupunctureDummy for GP-CAM anthroposophyDummy for GP-CAM homeopathyDummy for GP-CAM acupuncture*Age 0*--*24*Total6^a^100−320.016−0.138\*\*−0.052GP1−2\*10.015−0.043\*0.019Hospital376−50.064−0.153\*−0.034Pharmaceutical125−27−0.078\*−0.250\*\*\*−0.108Paramedic20−10.048−0.006−0.008*Age 25*--*49*Total14−50−66\*0.022−0.160\*\*−0.106\*\*GP2\*\*\*−3\*\*\*00.030\*\*−0.045\*\*−0.004Hospital34−47\*\*0.008−0.161\*\*−0.135\*\*Pharmaceutical8−51\*\*−17−0.035−0.365\*\*\*−0.136\*Paramedic1−1−2\*\*\*0.032−0.029−0.060\*\*\**Age 50*--*74*Total63−48−2−0.030−0.153\*\*−0.084GP4\*\*\*000.040\*−0.0010.017Hospital60−121−640.032−0.145−0.073Pharmaceutical−76961−0.204\*\*\*−0.352\*\*\*−0.162Paramedic6\*410.0800.016−0.009*Age 75+*Total−405\*\*81214−0.1300.0770.184GP−267−0.0300.0580.111Hospital−263\*\*5287−0.0290.0690.171Pharmaceutical−125\*31127−0.1690.0480.196Paramedic−15−8−7−0.106−0.0850.034\*\*\*, \*\*, \* indicate a statistically significant difference with conventional GP at the 1, 5, and 10% level, respectively^a^Costs of healthcare are in Euros per quarter. Each row is based on two regressions with either costs (left panel) or the natural logarithm of costs (right panel) as the dependent variable. Explanatory variables are gender, age (linear, within each age category), dummies for each quarter, dummies for anthroposophy, homeopathy, and acupuncture; the table reports the coefficients on the latter dummies. All regressions control for 6-digit insuree postcode fixed effects; standard errors clustered at the insuree level

It is important to note that 6-digit postal codes in the Netherlands are highly detailed, representing 16 households on average. Within such a code, households are highly homogeneous in terms of socioeconomic status. Given that we have controlled for 6-digit postal codes in the regressions, the results are unlikely to be due to differences in socioeconomic status.

Health status {#Sec11}
-------------

In the present dataset, the only information available on health outcomes is mortality in the years 2006 up to and including 2009. For the population of insurees in our data, the mortality rate was approximately 3%. After controlling for demographics (including age) and 4-digit postal codes, we find that patients with a GP-CAM have significantly lower mortality rates (Table [4](#Tab4){ref-type="table"}). For all three types of CAM, the effect is significant for some specifications, but not for all specifications. The magnitude of the effect again varies between 0 and 30%.Table 4Effects of complementary care on mortalityDummy for GP-CAM anthroposophyDummy for GP-CAM homeopathyDummy for GP-CAM acupunctureCombinedLogit with fixed effects0.031−0.198−0.333\*−0.128LPM with fixed effects−0.005\*−0.004−0.009\*\*−0.006\*\*\**Women*Logit with fixed effects0.0340.010−0.203−0.031LPM with fixed effects−0.007\*0.004−0.008−0.005\**Men*Logit with fixed effects0.020−0.627\*−0.493−0.291\*LPM with fixed effects−0.003−0.014−0.013\*\*−0.008\*\*Dependent variable: death in 2006, 2007, 2008, or 2009The table is based on models with the following explanatory variables: gender, age, dummies for anthroposophy, homeopathy, and acupuncture (dummy for complementary in the last column); the table reports the coefficients on the latter dummiesLPM regression controls for 4-digit insuree postcode fixed effects\*\*\*, \*\*, \* indicate a statistical significance at the 1, 5, and 10% level, respectively

Discussion {#Sec12}
==========

There are four types of explanations for the differences reported in the previous section. First, the differences could be due to selection on unobservables in patients' GP choice. For example, patients who are healthier and more health-conscious or patients with a strong preference to minimize exposure to medical interventions might be more likely to choose a GP-CAM. In both cases, costs will be lower due to lower demand for healthcare. A standard approach to control for selection on unobservables is to use instrumental variables. A potential instrumental variable (IV) in this case is the distance between a patient's home and the various GPs. However, the distance measures would be perfectly correlated with the 6-digit postal code dummies. As a consequence, this IV would only work if we would control for less detailed neighborhood information, like 4-digit postal codes. However, since socioeconomic differences within a 4-digit postal code are typically large, this would not be a credible approach for identifying a causal effect of CAM on costs.

Second, the results could be due to undertreatment by GP-CAMs. In the present dataset, we were only able to analyze mortality and found that patients with a GP-CAM tend to have lower mortality rates. A number of studies have reported that patients seeking anthroposophic or homeopathic care have longer lasting and more severe health problems than patients in conventional care. At the same time, these patients report fewer adverse side effects of treatments and higher patient satisfaction (e.g., \[[@CR20], [@CR21]). These findings combined with the results in this study provide some indication that undertreatment by GP-CAMs is unlikely. Firmer conclusions require more data on outcomes.

Thirdly, the results could be due to better practices of CAM due to a stronger focus on preventive and curative health promotion and less overtreatment. For example, a GP-CAM might try a low-cost CAM treatment first. As mentioned, the primary professional orientation of CAM doctors is to strengthen the self-healing capacity of the body and the self-management of the patient. This approach is associated with prescribing fewer conventional pharmaceuticals, tests, and operations.

Fourthly, the lower costs could be related to the fact that patients interested in CAM might have higher out-of-pocket expenses since CAM is not included in the basic health insurance package. On the other hand, patients interested in CAM are more likely to buy supplementary insurance that covers CAM. This would imply that the marginal out-of-pocket expenses for these insurees are lower than for insurees with a conventional GP, leading to *more* consumption of healthcare (recall that the Azivo data contain costs covered by basic health insurance plus costs covered by optional supplementary health insurance). Yet, we find that the costs of patients with a GP-CAM are lower. Clarifying the role of out-of-pocket expenses is an empirical issue that requires additional data.

Several studies that compare the health status of patients treated in CAM and in conventional medicine in primary care settings find that patients treated in CAM practices suffer more often from severe and chronic illnesses (e.g., \[[@CR20], [@CR21]\]). This suggests that if we could control for severity and chronicity of illnesses (with additional data), the estimated cost differences might be larger.

Another result of this study is that GP-CAMs have a larger fraction of female patients than conventional GPs and fewer patients from disadvantaged neighborhoods. Similar findings have been reported for the US \[[@CR22]\] and for Switzerland \[[@CR20]\].

The major limitations of this study concern the limited dataset. First of all, the dataset is from only one insurer in one specific Dutch region, and the data reflect the behavior of only a small number of GPs with additional training in CAM. This challenges the generalizability of the results. Secondly, the dataset does not cover all the information needed to perform an optimal comparison of cost-effectiveness. Missing information includes costs distinguished by basic and supplementary insurance, out-of-pocket expenses, morbidity, work absence, subjective health, and patient satisfaction.

Consequently, a large number of issues remain for future research. We mention three of them specifically. First, replication studies based on similar datasets are needed to confirm the present results. Secondly, further research is needed to determine to what extent selection on unobservables and causal effects explain the lower costs and lower mortality rates of patients with a GP-CAM. Thirdly, more research is needed with regard to the cost-effectiveness of CAM for specific diagnostic categories.
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